Medical Laboratories - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Medical industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Medical Laboratories - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Medical Laboratories
Corporate Insider Buy Sell Ratio (Insider Count) - Medical Laboratories
Medical Laboratories - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2029-06-23 NTRA / Natera, Inc. 4 Brophy Michael Burkes M - Exercise D -12,500
2029-06-08 NTRA / Natera, Inc. 4 Brophy Michael Burkes M - Exercise D -25,000
2026-06-04 GH / Guardant Health, Inc. 4 Krognes Steve E. S - Sale D 132.5072 -9,294
2026-06-04 VCYT / Veracyte, Inc. 4 Leite John S - Sale D 50.0703 -13,975
2026-06-04 PSNL / Personalis, Inc. 4 Tachibana Aaron S - Sale D 12.01 -40,000
2026-06-04 VCYT / Veracyte, Inc. 4 Chambers Rebecca S - Sale D 50.0913 -1,961
2026-06-04 VCYT / Veracyte, Inc. 4 Chambers Rebecca S - Sale D 49.2836 -1,600
2026-06-04 VCYT / Veracyte, Inc. 4 Stapley Marc S - Sale D 50.1234 -138,051
2026-06-04 NTRA / Natera, Inc. 4 Chapman Steven Leonard S - Sale D 213.4440 -2,503
2026-06-04 NTRA / Natera, Inc. 4 Chapman Steven Leonard S - Sale D 216.1344 -5,499
2026-06-04 NTRA / Natera, Inc. 4 Chapman Steven Leonard S - Sale D 214.8300 -1,300
2026-06-04 NTRA / Natera, Inc. 4 Chapman Steven Leonard S - Sale D 220.1875 -2,400
2026-06-04 NTRA / Natera, Inc. 4 Chapman Steven Leonard S - Sale D 218.2847 -1,742
2026-06-04 NTRA / Natera, Inc. 4 Chapman Steven Leonard S - Sale D 226.1472 -6,751
2026-06-04 NTRA / Natera, Inc. 4 Chapman Steven Leonard S - Sale D 212.4187 -832
2026-06-04 NTRA / Natera, Inc. 4 Chapman Steven Leonard S - Sale D 217.0396 -2,351
2026-06-04 VCYT / Veracyte, Inc. 4 McGuire Annie S - Sale D 50.1168 -1,776
2026-06-04 NTRA / Natera, Inc. 4 Chapman Steven Leonard S - Sale D 226.9699 -3,409
2026-06-04 NTRA / Natera, Inc. 4 Chapman Steven Leonard S - Sale D 223.9093 -1,443
2026-06-04 VCYT / Veracyte, Inc. 4 McGuire Annie S - Sale D 49.3061 -1,400
2026-06-04 NTRA / Natera, Inc. 4 Chapman Steven Leonard S - Sale D 219.0806 -2,758
2026-06-04 NTRA / Natera, Inc. 4 Chapman Steven Leonard S - Sale D 223.3354 -6,500
2026-06-04 NTRA / Natera, Inc. 4 Chapman Steven Leonard S - Sale D 222.2469 -2,006
2026-06-04 NTRA / Natera, Inc. 4 Chapman Steven Leonard S - Sale D 224.9918 -1,630
2026-06-04 VCYT / Veracyte, Inc. 4 Stapley Marc M - Exercise D 36.60 138,051
2026-06-04 PSNL / Personalis, Inc. 4 Tachibana Aaron M - Exercise D 9.16 40,000
2026-06-03 GH / Guardant Health, Inc. 4 Joyce Meghan V. S - Sale D 126.5157 -3,516
2026-06-03 GH / Guardant Health, Inc. 4 Joyce Meghan V. S - Sale D 129.3111 -106
2026-06-03 GH / Guardant Health, Inc. 4 Joyce Meghan V. S - Sale D 127.1054 -5,728
2026-06-03 GH / Guardant Health, Inc. 4 Joyce Meghan V. S - Sale D 128.0196 -650
2026-06-03 GH / Guardant Health, Inc. 4 Joyce Meghan V. M - Exercise D 38.005 8,803
2026-06-03 GH / Guardant Health, Inc. 4 Joyce Meghan V. M - Exercise D 38.42 1,197
2026-06-02 FLGT / Fulgent Genetics, Inc. 4 Xie Jian S - Sale D 17.8855 -2,146
2026-06-02 FTRE / Fortrea Holdings Inc. 4 Mcconnell Jill G. S - Sale D 15.49 -4,866
2026-06-02 FLGT / Fulgent Genetics, Inc. 4 Gao Hanlin S - Sale D 17.8855 -1,688
2026-06-02 FTRE / Fortrea Holdings Inc. 4 Morais Mark A. S - Sale D 15.49 -4,866
2026-06-02 CELC / Celcuity Inc. 4 Laing Lance G. M - Exercise D 9.89 1,000
2026-06-02 VCYT / Veracyte, Inc. 4 Chambers Rebecca F - Taxes D 47.80 -3,693
2026-06-02 VCYT / Veracyte, Inc. 4 Wygant Jonathan F - Taxes D 47.80 -1,361
2026-06-02 VCYT / Veracyte, Inc. 4 Stapley Marc F - Taxes D 47.80 -9,012
2026-06-02 VCYT / Veracyte, Inc. 4 Leite John F - Taxes D 47.80 -4,059
2026-06-02 VCYT / Veracyte, Inc. 4 Febbo Phillip G. F - Taxes D 47.80 -3,730
2026-06-02 VCYT / Veracyte, Inc. 4 McGuire Annie F - Taxes D 47.80 -3,292
2026-06-02 RDNT / RadNet, Inc. 4 SWARTZ DAVID L A - Award D 2,946
2026-06-02 RDNT / RadNet, Inc. 4 SPURLOCK GREGORY E. A - Award D 2,946
2026-06-02 RDNT / RadNet, Inc. 4 Levitt Lawrence L A - Award D 2,946
2026-06-02 RDNT / RadNet, Inc. 4 Jacobs Laura Pastre A - Award D 2,946
2026-06-01 NTRA / Natera, Inc. 4 BOTHA ROELOF Estate planning vehicles S - Sale I 218.6881 -26,411
2026-06-01 CSTL / Castle Biosciences, Inc. 4 MAETZOLD DEREK J By The Maetzold 2018 Remainder Trust FBO John Derek Maetzold S - Sale I 20.857 -278
2026-06-01 CSTL / Castle Biosciences, Inc. 4 MAETZOLD DEREK J By The Maetzold 2018 Remainder Trust FBO Peter Douglas Maetzold S - Sale I 20.857 -278
P
공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매입
S
공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매각
A
자사로부터 유가증권(옵션 등)을 보조, 지급 또는 기타 취득
C
파생상품 전환
D
자사에게 유가증권을 매각 또는 양도
F
기업으로부터 인도 받은 유가증권의 일부를 사용한 행사 가격 또는 조세 채무의 지급
G
내부자에 의한 또는 내부자에게 증권 증여
K
지분스왑 및 유사 위험 회피거래
M
자사로부터 인도 받은 파생증권(옵션 등)의 행사 또는 전환
V
보고서 양식 4에 자진 신고된 거래
J
기타 (거래 내용을 설명하는 각주와 동반)